GPC3/​Mesothelin-CAR-γδT / Second Affiliated Hospital of Guangzhou Medical University - LARVOL DELTA

GPC3/Mesothelin-CAR-γδT Cells Against Cancers (clinicaltrials.gov) - P1 | N=30 | Recruiting | Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Not yet recruiting ➔ Recruiting | Trial completion date: Dec 2033 ➔ Dec 2036 | Initiation date: Jan 2024 ➔ May 2024 | Trial primary completion date: Nov 2026 ➔ Nov 2030

Enrollment open • Trial completion date • Trial initiation date • Trial primary completion date • Gastrointestinal Cancer • Hepatology • Liver Cancer • Lung Cancer • Mesothelioma • Oncology • Pancreatic Cancer • Solid Tumor